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Overexpression of Cathepsin S Induces Chronic
Atopic Dermatitis in Mice
Nari Kim1,5, Ki Beom Bae1,5, Myoung Ok Kim1, Dong Hoon Yu1, Hei Jung Kim1, Hyung Soo Yuh1,
Young Rae Ji1, Si Jun Park1, Sol Kim2, Kyu-Hee Son2, Sang-Joon Park2, Duhak Yoon3, Dong-Seok Lee1,
Sanggyu Lee1, Hyun-Shik Lee1,6, Tae-Yoon Kim4,6 and Zae Young Ryoo1,6
Atopic dermatitis (AD) is a chronically relapsing, noncontagious pruritic skin disease with two phases: acute and
chronic. Previous studies have shown that the cysteine protease cathepsin S (CTSS) is linked to inflammatory
processes, including atherosclerosis and asthma. The possibility that this or other cysteine proteases might
cause itching or be part of a classical ligand–receptor signaling cascade has not been previously considered.
Recently, CTSS was shown to be a ligand for proteinase-activated receptor-2 (PAR-2), which is associated with
itching. In this study, we show that CTSS-overexpressing transgenic (TG) mice spontaneously develop a skin
disorder similar to chronic AD. The results of this study suggest that CTSS overexpression triggers PAR-2
expression in dendritic cells (DCs), resulting in the promotion of CD4þ differentiation, which is involved in
major histocompatibility complex (MHC) class II expression. In addition, we investigated mast cells and
macrophages and found significantly higher mean levels of T helper type 1 (Th1) cell–associated cytokines than
T helper type 2 (Th2) cell–associated cytokines in CTSS-overexpressing TG mice. These results suggest that
increased PAR-2 expression in DCs as a result of CTSS overexpression induces scratching behavior and Th1
cell–associated cytokine expression, and can trigger chronic AD symptoms.
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INTRODUCTION
Atopic dermatitis (AD) has long been a problem for
immunologists because it is associated with a wide range of
immunological abnormalities (Coombs, 1963). The course of
AD comprises two phases: acute AD with T helper type 2
(Th2) predominance and chronic AD with T helper type 1
(Th1) cell–associated cytokine expression. Several other
observations suggest that Th1 cells, rather than Th2 cells,
are important in the pathogenesis of AD (Grewe et al., 1998).
Cathepsin S (CTSS) is a lysosomal cysteine protease that
can function as an elastase over a broad pH range in alveolar
macrophages and may participate in the degradation of
antigenic proteins to peptides for presentation on major
histocompatibility complex (MHC) class II molecules. Re-
cently, human CTSS was shown to activate human protea-
se–activated receptor-2 (PAR-2), consistent with a possible
pruritic role in inflammatory skin diseases such as AD
(Reddy et al., 2010).
PAR-2 is member of the G-protein–coupled receptor
family (Vu et al., 1991). Serine proteases cleave receptors
within their N termini. They thereby expose a tethered ligand
domain that binds and activates the cleaved receptor. The
only endogenous proteases known to activate PAR-2 are
serine proteases, i.e., proteases with serine residues in their
active sites, which include trypsin, tryptase, and several
kallikrein-related peptidases (Steinhoff et al., 1999; Oikono-
mopoulou et al., 2006; Stefansson et al., 2008). Tryptase and
PAR-2 are involved in serine protease–mediated receptor
activation and itching (Steinhoff et al., 2000, 2003).
Mucunain is an inducer of histamine-independent itch
(Arthur and Shelley, 1955; Shelley and Arthur, 1955). The
recent findings that mucunain, which is an exogenous
cysteine protease and the active component of cowhage
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(or cowitch; Mucuna pruriens), and CTSS evoke itching and
activate PAR-2 extended these observations (Reddy et al.,
2008, 2010). CTSS shares active site sequence homology
with cowhage and binds to PAR-2 (Johanek et al., 2007),
which leads to the stimulation of C fibers (Namer et al.,
2008). This pathway is distinct from the neuronal circuits
transmitting histamine itch (Davidson et al., 2007). The
cleavage site for cysteine protease activation of PAR-2
remains to be identified. In addition, the presence of PAR-2
on free nerve endings in the skin, keratinocytes, dendritic
cells (DCs), and dorsal root ganglia suggests a link between
this receptor and both itching and pain (Steinhoff et al., 2000,
2003).
Because of the overall implications of these findings with
respect to the physiological role of CTSS, we postulated that
CTSS overexpression may be responsible for boosting itching
and scratching. Therefore, we focused on the role of CTSS in
the induction of chronic AD in vivo.
RESULTS
CTSS induces PAR-2 overexpression in CTSS-overexpressing
mice
The human CTSS gene (GenBank NM_004079) was ampli-
fied from human placental RNA. To induce overexpression in
mice, a BamHI–XhoI fragment containing full-length human
CTSS complementary DNA (cDNA) was cloned into the
pEGFP-N1 vector, which contains the cytomegalovirus
promoter (Figure 1a). CTSS overexpression was examined in
various tissues and compared with wild-type (WT) expression
by reverse transcription–PCR (RT–PCR). Transgenic (TG) mice
showed high overall expression of CTSS in the skin, as well as
in other tissues (Figure 1b–d).
AD symptoms in CTSS-overexpressing mice
We observed significant morphological changes in TG mice.
These changes included reddening and scaling of the dorsal
skin and neck region, frequent face rubbing, and scratching
(Figure 2a). Because pruritus is one of the major symptoms of
AD, we examined scratching behaviors in the mice. Total
scratching counts in TG mice were significantly higher than
those in WT mice. In addition, TG mice exhibited increased
scratching behavior with increased AD severity (Figure 2b).
Aggravation of inflammation and mast cell accumulation
The skin histology in hematoxylin and eosin and toluidine
blue staining showed a progressive increase in inflammatory
cell infiltration in the epidermis and dermis of 16-week-old
TG mice as the disease progressed. TG samples were
distinguished from WT ones by a substantial increase in
epidermal hyperproliferation, epidermis rupture, dermis
thickness, and infiltration of mast cells, which is a histological
marker of chronic inflammation in AD (Figure 3a). Notably,
defects in keratinocyte proliferation are an important
component in the pathogenesis of AD. TG mice showed
increased keratinocyte proliferation and differentiation in the
basal and suprabasal layers of the epidermis (Figure 3d).
Proliferating cell nuclear antigen- and Ki67-positive cells
indicated keratinocyte proliferation in the epidermis (visua-
lized by K10 staining). Moreover, the dermis in the TG
samples was densely infiltrated by mast cells (Figure 3b). The
numbers of mast cells were higher in TG samples than in
those from WT mice (Figure 3c).
Increased PAR-2 expression is caused by CTSS overexpression
We were interested in the effect of CTSS overexpression on
PAR-2 expression. We performed real-time PCR analysis of
dorsal skin tissue from WT mice and TG mice with AD of
different severity. TG mice exhibited increasing CTSS and
PAR-2 expression with increasing AD severity compared with
WT mice (Figure 4a and b). We performed western blotting to
further quantify CTSS and PAR-2 protein expression in 16-
week-old mice. Expression of CTSS and PAR-2 was sig-
nificantly increased (Figure 4c), supporting the utility of
CTSS-overexpressing TG mice in investigating the role of
the interaction between CTSS and PAR-2 in the pathogenesis
of AD.
We performed immunohistochemical staining in 16-week-
old mice. We examined CTSS overexpression, which was
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Figure 1. Cathepsin S (CTSS)-overexpression vector construction and
transgene expression in various tissues. (a) We used the cytomegalovirus
(CMV) promoter to overexpress CTSS in the whole body. EGFP, enhanced
green fluorescent protein; ORF, open reading frame. (b, c) The primers used
for PCR in various tissues are indicated; they yielded 605 bp bands, indicating
expression of the CTSS transgene in 6-week-old mice. (d) Relative CTSS
mRNA expression in 6-week-old mice. Filled columns, TG; open columns,
WT. BAT, brown adipose tissue; Br, brain; He, heart; Ki, kidney; Li, liver; Lu,
lung; Sk, skin; Te, testis; TG, CTSS-overexpressing transgenic mice; WAT,
white adipose tissue; WT, C57BL/6 wild-type mice. The columns and error
bars represent the means±SEM of three independent experiments. Statistics:
Student’s t-test. *Po0.01, **Po0.001 compared with WT controls.
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found to result in marked induction of PAR-2 expression in
the epidermis and dermis of TG mice compared with WT
controls (Figure 4d). Notably, expression of both CTSS and
PAR-2 was strongly increased in the thickened epidermis,
indicating that overexpression of the two genes was
correlated with hyperkeratosis (see also Figure 3d).
A recent study indicated that PAR-2 is expressed in DCs
and may have a significant role in priming the Th cell
response by inducing DC maturation (Lim et al., 2006). A
fully mature DC displays CD11c and MHC class II on its
membrane. We found high levels of CD11c expression in the
epidermis and dermis of TG mice (Figure 4d). In addition, we
found high levels of molecules typically expressed by DCs,
such as CD4 and MHC class II (Figure 4e). Therefore, our
results suggest that there is a positive relationship between
CTSS and PAR-2, supporting the role of DC maturation in
CD4þ T-cell stimulation. We next examined the presence
and degree of inflammatory cell infiltration in the skin. Our
results indicated significant infiltration of cells expressing
CD68, a marker for macrophages, in the skin of TG mice
(Figure 4e).
Increased production of cytokines, chemokines, and IgE
As cytokines and chemokines orchestrate atopic skin
inflammation, their mRNA and protein levels were examined
in skin from 16-week-old WT and TG mice by RT–PCR and
ELISA. In TG mice, we found increased levels of transcripts
for Th2-type cytokines, including IL-4 and IL-10, which were
not detected in WT controls. Interestingly, transcripts for the
Th1-type cytokines tumor necrosis factor-a, IFN-g, IL-2, and
IL-1b were also upregulated in TG mice (Figure 5a). In
addition, increased transcript levels of the chemokines
monocyte chemotactic protein-1 and granulocyte macro-
phage-colony stimulating factor were found in TG mice
(Figure 5a). These chemokines attract monocytes to inflam-
matory lesions and induce proliferation and differentiation.
Next, we performed ELISA to further examine cytokine
expression. The results were similar to those of RT–PCR, but
we observed greater increases in Th1-type cytokines,
especially IFN-g, as compared with Th2-type cytokines in
TG mice compared with WT (Figure 5b). The Th2-mediated
response showed a relatively small effect as compared with
the Th1-mediated response in TG mice. Therefore, we
concluded that the Th1-mediated response is the main factor
responsible for the rapid development of chronic inflamma-
tion in TG mice.
We also found that serum IgE levels were an average
of 2-fold higher in TG mice as compared with WT controls
(Figure 5c).
DISCUSSION
AD is a type of eczema or skin inflammation that arises from
an allergic reaction. It causes an itchy rash that becomes
crusty and scaly with scratching, and is often associated with
elevated serum IgE levels (Hanifin and Rajka, 1980; Rudikoff
and Lebwohl, 1998; Leung and Bieber, 2003). Although the
precise causes of AD are not entirely understood, most
evidence suggests that complex immune dysregulation and
environmental allergenic susceptibility are both involved in
the underlying etiology (Kang et al., 2010).
Cysteine proteases belong to the papain family, and 11
isoforms have been identified to date. The majority of
cysteine proteases are localized in acidic vesicles, lysosomes,
and endosomes, where they possess highly specific and
directed proteolytic activity (Chapman et al., 1997; Turk
et al., 2000). Their participation in antigen processing and
proteolytic proprotein activation (Riese and Chapman, 2000;
Brix et al., 2001; Rudensky and Beers, 2006) indicates their
pivotal roles in numerous cellular events, and secreted
cysteine proteases have the capacity to promote remodeling
of the extracellular matrix during wound healing and tumor
cell invasion (Baici, 1998; Brix, 2005; Mohamed and Sloane,
2006). In marked contrast to other isoforms, CTSS can
function both inside and outside of the lysosomes (Wieder-
anders et al., 1991). In the extracellular compartment, CTSS
exhibits a large portion of its proteolytic activity at a neutral
pH, which is a specific feature of this isoform (Bromme et al.,
1993).
In this study, CTSS-overexpressing TG mice were gener-
ated using the cytomegalovirus promoter, which induced
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Figure 2. Atopic dermatitis phenotype in cathepsin S (CTSS)-overexpressing
mice. (a) Appearance of 16-week-old WT and TG mice. (b) Scratch bouts
were counted for 60minutes (n¼3). TG, CTSS-overexpressing transgenic
mice; WT, C57BL/6 wild-type mice. The columns and error bars represent the
means±SEM of three independent experiments. Statistics: Student’s t-test.
*Po0.05, **Po0.01 compared with WT controls.
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CTSS expression in various tissues. However, this study
focused on skin tissue because marked skin defects were
observed in TG mice. In future studies, we will access
abnormalities and changes caused by CTSS overexpression in
other organs. Protein alignment revealed that human CTSS is
very similar to its mouse counterpart with which it shares
74% overall homology (data not shown). However, there is a
small possibility that the observed results could have resulted
from overexpression of a foreign protease. In this TG mouse
model, the onset of AD occurred spontaneously at the age of
14–16 weeks, and the disease progressed rapidly to the extent
that the lesions coveredB40% of the body. TG mice showed
vigorous scratching at varying times, which triggered even
more skin irritation than did the initial lesions (Figure 2).
NC/Nga mice were derived from Japanese fancy mice
(Nishiki-Nezumi) and were established as an inbred strain in
1955. Some Japanese researchers noticed the spontaneous
development of dermatitis just before or after weaning (Suto
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Figure 3. Cathepsin S (CTSS)-overexpressing mice develop chronic skin inflammation. (a) Hematoxylin and eosin (H&E) staining. (b) Toluidine blue
staining. Mast cells show purple staining. Scale bar¼ 50 mm. (c) Mast cell numbers were counted. (d) Analysis of keratinocyte proliferation in the epidermis.
Arrowheads identify proliferating keratinocytes, and dotted lines identify the boundaries between the epidermis (ED) and dermis (DE). Positive cells show brown
staining. Bar¼ 200 mm. Filled columns, TG; open columns, WT. PCNA, proliferating cell nuclear antigen; TG, CTSS-overexpressing transgenic mice;
WT, C57BL/6 wild-type mice. The columns and error bars represent the means±SEM of three independent experiments. Statistics: Student’s t-test. *Po0.05
compared with WT controls.
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et al., 1999). NC/Nga mice display clinical and histological
features that are very similar to those that characterize AD
(Suto et al., 1999). Furthermore, NC/Nga mice with skin
lesions frequently scratch their faces, ears, and the rostral
parts of their backs using their hind paws (Tohda et al., 1997).
Features similar to these were seen in CTSS-overexpressing
TG mice.
Similar to NC/Nga mice, CTSS-overexpressing TG mice
showed expression of Th2-type cytokines from allergen-
specific Th2 cells in AD. IL-4 and IL-10 act on B cells to
induce IgE synthesis (Farrar et al., 2002). IL-6 and IL-10 block
the generation of Th1 cells from naive T cells (Murphy et al.,
2000; Feizy and Ghobadi, 2006). Interestingly, we showed
marked increases in the levels of the Th1-type cytokines
tumor necrosis factor-a, IFN-g, IL-2, and IL-1b, which
have important roles during the chronic phase of AD. In
AD, Th1 cytokines such as tumor necrosis factor-a and IL-1b
from resident cells (keratinocytes, mast cells, and DCs)
bind to receptors on the vascular endothelium, activating
cellular signaling pathways. In addition, they induce
expression of vascular endothelial cell adhesion molecules
and IL-2, which are important for T-cell growth and
activation (Ahn et al., 2010). In previous studies, the marked
expression of IFN-g was shown to be involved in chronic
eczematous AD skin lesions and was suggested to be
related to the activation of tissue macrophages (Grewe
et al., 1994; Tsicopoulos et al., 1994), which have an
important role in skin hypertrophy during delayed hypersen-
sitivity reactions. These findings were consistent with our
observation that TG mice showed relatively strong expression
of IFN-g, resulting in thickening of the epidermal and
dermal layers.
The key questions with respect to the pathophysiology of
chronic AD are how CTSS is initiated and maintained and
whether CTSS itself may have a role. We found that
epidermal hyperproliferation accompanies an increase in
itch and scratching. PAR-2 is expressed on endothelial and
immune cells, and has been implicated in DC differentiation.
DCs are strong candidates to explain how PAR-2 modulates
the immune response during inflammation (Allshurafa et al.,
2004). PAR-2 expression on the surface of DCs induces
stimulation of CD4þ T cells, which produce IFN-g,
consistent with a Th1 phenotype (Csernok et al., 2006). The
results of this study indicate that CTSS induces PAR-2
expression, resulting in DC maturation, as indicated by the
expression of CD11c and MHC class II. These CTSS-matured
DCs stimulated CD4þ T cells to increase the expression of
Th1-type cytokines.
In conclusion, increased PAR-2 activation caused by
CTSS contributed to the development of AD. CTSS over-
expression induced the expression of PAR-2 on DCs, and
PAR-2-matured DCs stimulated CD4þ T cells, which
produced Th1-type cytokines in CTSS-overexpressing TG
mice. These findings may improve our understanding of the
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Figure 4. Proteinase-activated receptor-2 (PAR-2) expression and inflammatory cell infiltration in dorsal skin. Real-time PCR analysis of (a) cathepsin S
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development of AD with enhancement of both Th1- and Th2-
mediated immunological responses, especially how Th1
cytokines contribute to chronic inflammation in AD. In
addition, CTSS-overexpressing TG mice showed increased
mast cell infiltration, hyperproduction of IgE, and keratino-
cyte hyperproliferation. Our findings suggest that CTSS-
overexpressing TG mice may be useful as a model of chronic
AD. This model will provide insights into the pathogenesis of
this condition as well as facilitate the development of
treatment regimens.
MATERIALS AND METHODS
Plasmid construction
A BamHI–XhoI fragment containing full-length human CTSS cDNA
was cloned into the pEGFP-N1 vector driven by the cytomegalovirus
promoter. This expression cassette was prepared for microinjection
by digesting the recombinant vector with restriction enzymes.
Generation and screening of transgenic mice
The transgene construct was microinjected into embryos obtained
from female C57BL/6J mice. Microinjected embryos were transferred
into the oviducts of pseudopregnant female ICR mice.
To isolate TG mice, total genomic DNA was extracted from the
biopsied tails of founder candidates, and PCR screening was
performed. The following primers were used: pEGFP-N1 forward
(50-CGTGTACGGTGGGAGGTCTA-30) and pEGFP-N1 reverse (50-
TGGTGCAGATGAACTTCAGG-30). PCR was performed as 30 cycles
of 94 1C for 30 seconds, 57 1C for 30 seconds, and 72 1C for
40 seconds.
Two transgenic founder mice were identified based on the results
of this screening. Each founder mouse was mated with WT C57BL/6J
mice. The offspring produced as a result of this mating were
genotyped through PCR analysis of tail lysates. Offspring that did not
inherit the transgene were used as controls.
All mice were generated by a standard procedure (Hogan
et al., 1986). They were raised and maintained under conventional
conditions in a room with a 12-hour light/dark cycle, and a controlled
temperature (23 1C), and were given free access to food and water.
All animal experiments were carried out in accordance with the
guidelines for animal experimentation and under permission from
the Institutional Animal Care and Use Committee. At 6 weeks of age,
pups were raised individually (one per cage) under the same
conditions. At the beginning of the experiment, 20 WT and 20 TG
male mice aged 16 weeks were used.
RT–PCR analysis
Patterns of human CTSS mRNA expression in various tissues were
assessed by RT–PCR.
Total RNA was isolated from various tissues from 6-week-old
WT and TG mice using TRIzol reagent (MRC, Cincinnati, OH)
according to the manufacturer’s instructions. Total RNA was reverse
transcribed for 1 hour at 42 1C using AMV reverse transcriptase
(Promega, Madison, WI). The synthesized cDNAs were amplified
using the following primers: CTSS forward (50-TGGATCACCACTG
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GCATCTCT-30) and CTSS reverse (50-TGAACATGTGGCAGCAC
GAT-30). After denaturation for 5minutes at 94 1C, PCR was per-
formed as 30 cycles of 94 1C for 30 seconds, 59 1C for 30 seconds,
and 72 1C for 30 seconds. The GAPDH gene was used as an internal
control. Additional RT–PCR analyses were conducted to confirm the
levels of various cytokines and chemokines (see Supplementary
Table S1 online).
Quantitative real-time PCR analysis
cDNAs were synthesized from dorsal skin tissue from 13-week-old
WT and TG mice.
Real-time PCR was performed using a Step One Plus PCR system
(Applied Biosystems, Foster City, CA), which exploited the ability of
SYBR Green to fluoresce after hybridization with double-stranded
DNA. The following primers were used: CTSS forward (50-CGGCTG
GTTTGTGTGCTCTT-30), CTSS reverse (50-AGAGATGCCAGTGGTG
ATCCA-30), PAR-2 forward (50-CGATGAGTTCTCTGCGTCCAT-30),
and PAR-2 reverse (50-GCCATTACTGGGCAAACCAA-30). After an
initial denaturation step at 95 1C for 30 seconds, PCR was performed
as 50 cycles of denaturation at 95 1C for 5 seconds, annealing at
60 1C for 30 seconds, and elongation at 72 1C for 10 seconds. The
GAPDH gene was used as an internal control for quantification.
Levels of CTSS, PAR-2, and GAPDH gene expression in all cDNA
samples were determined based on SYBR Green fluorescence using
Step One software, version 2.1 (Applied Biosystems).
Behavioral experiments
We observed individual animals for 60minutes, during which time
we counted bouts of scratching. A bout of scratching was defined as
the animal lifting a hind paw from the cage floor, scratching with the
paw, and returning the paw to the floor. Animals were tested in the
cages in which they were housed.
Antibodies
The following antibodies were used: anti-mouse cytokeratin 10 (K10)
monoclonal antibody (Covance, Princeton, NJ), anti-rabbit Ki67
monoclonal antibody (Thermo, Hudson, CA), anti-mouse proliferat-
ing cell nuclear antigen monoclonal antibody, anti-goat CTSS poly-
clonal antibody, anti-rabbit PAR-2 polyclonal antibody, anti-mouse
MHC class II monoclonal antibody (Santa Cruz Biotechnology, Santa
Cruz, CA), anti-hamster CD11c monoclonal antibody, anti-rabbit
CD4 polyclonal antibody (Novus Biologicals, Littleton, CO), and
anti-rat macrophage monoclonal antibody (Abcam, Cambridge, UK).
Histology and immunohistochemistry
Skin sections were excised from dorsal skin from 16-week-old WT
and TG mice. Tissues were fixed through incubation in Bouin’s
solution for 1 day and embedded in paraffin. The paraffin-embedded
tissues were sectioned to a thickness of 3–5mm. Tissue sections were
mounted on glass slides. The slides were deparaffinized before
staining.
For histological assessment, tissue sections were stained with
hematoxylin and eosin and toluidine blue. In some experiments,
numbers of mast cells in 10 randomly selected low-power fields
were counted.
For immunohistochemistry, tissue sections were fixed in Bouin’s
solution, subjected to antigen retrieval (cooking for 3minutes
in 0.01M citrate buffer, pH 6.0), and incubated with 3% normal
serum. They were then washed with phosphate-buffered saline and
immunostained with primary antibody and the corresponding
secondary antibody. Representative images were captured using
LSM 510 Meta confocal microscope (Carl Zeiss, Hertfordshire, UK).
Western blot analysis
CTSS and PAR-2 protein levels were determined by western blotting
using specific antibodies. Dorsal skin tissues were washed twice
with phosphate-buffered saline, and tissue lysates were then
prepared in a lysis buffer containing 50mM Tris–HCL (pH 8.0),
150mM NaCl, 1% NP-40, and protease inhibitor cocktail (Sigma,
St Louis, MO). Proteins were resolved by SDS-PAGE. As a loading
control, tissue lysates were blotted with anti-b-actin antibody.
C57BL/6 mice were used as a control.
Cytokine and IgE ELISA
Cytokine levels in dorsal skin tissue extracts were measured by a
sandwich ELISA (R&D Systems, Minneapolis, MN). Briefly, a 96-well
plate was coated with monoclonal capture antibody. After washing
and blocking steps, standards and samples were then added. The
plate was incubated for 2 hours, and biotinylated detection antibody
was added. The color reaction was generated using a substrate
solution containing tetramethylbenzidine and hydrogen peroxide.
The reaction was terminated by the addition of 1 M sulfuric acid, and
the optical density at 450 nm was determined using a microplate
reader with wavelength correction at 550 nm. Three washes with
blocking buffer were performed between the different steps.
For measurement of total IgE, blood samples (5ml) were collected
from the tail vein, and serum IgE levels were determined using an
ELISA kit (BioLegend, San Diego, CA).
Statistical analyses
The results are expressed as means±SEM of at least three inde-
pendent experiments. Groups were compared using Student’s t-test.
In all analyses, Po0.05 was taken to indicate statistical significance.
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